Viralytics
| Use attributes for filter ! | |
| Headquarters location | Sydney, Australia |
|---|---|
| Founded | 2006 |
| Key person | Paul A. Hopper |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2992077 |
About Viralytics
Viralytics Ltd is an Australian biotechnology company working in the field of oncolytic viruses, that is, viruses that preferentially infect and kill cancer cells. The company's oncolytic virus product, called Cavatak, is currently in clinical trials in metastatic melanoma and other cancers.
